We just posted new work from the lab on using CRISPR screens in cell lines to prioritise new oncology drug targets. 1/ Wellcome Sanger Institute EMBL-EBI Open Targets @Francesco_i0ri0 Fiona @emanuelvgo Javier Antonio Sáez Rodríguez biorxiv.org/content/early/…

Labtrip to EMBL for the awesome AEK conference!

Eventtipp: Heute startet das #WissensDurst-Festival 2019 (6.-8. Mai) | Mit Spitzenforscher/innen über Wissenschaft und #Grundlagenforschung im Pub plaudern #wisskomm

A rare opportunity for immunologists: the IMP invites applications for a group leader position in the field of #immunology. Please RT! Job ad & application form: imp.ac.at/career/open-po…

“With the number of known #coronavirus cases today in South Korea, Italy, Iran, France, Spain and the US, Wuhan was already in lockdown.” Read why every day we wait to make decisions is costlier that’s the previous: link.medium.com/JbJzTUPiK4

We haven't even started with the nose yet science.sciencemag.org/content/early/… Science Magazine

Die EMA hat soeben verlautbart, dass man nicht weiß ob die Sinusvenenthrombosen mit der Impfung zusammenhängen. Hier ist einer der Gründe weshalb es so schwierig ist das herauszufinden.

Monkey MindPong youtu.be/rsCul1sp4hQ

Today we report a new innate immune sensing pathway that detects virulence factors from viruses. nature.com/articles/s4158…

Our latest manuscript is in bioRxiv! This project was huge effort by Juline Poirson and Akash Dhillon in the lab and our first (but hopefully not last) foray into targeted protein degradation and stabilization. 1/ biorxiv.org/content/10.110…

Paper out! 🎉🎉🎉 So happy to share our newest paper on the discovery of LYSET (lysosomal enzymes trafficking factor). A great team work from the labs of Wilhelm Palm and @johannes_zuber (DKFZ and IMP) 😁👌 science.org/doi/10.1126/sc…

Nice study highlighting the power of genetics for drug development.

$CRSP submits first clinical trial application in Europe for a CRISPR-based therapy in beta-thalassemia bit.ly/2ABxYok

Now available: #CRISPRscreen data from 391 #cancer lines, incl 51 lines (rep'ing 14 tumors) not previously screened: broad.io/achilles Accompanying CCLE #RNAseq + #wholeexome profiles: broad.io/CCLEdata

IMP's Hannes Zuber & Stefan L Ameres of IMBA imbavienna.bsky.social alongside other Vienna BioCenter researchers combine cutting-edge #SLAMseq technology to decipher regulatory functions of important #cancer genes - published in 'Science'. Full story: tinyurl.com/y766cb5k #rna #BRD4, #MYC